ID

40994

Description

Adjuvant Endocrine Therapy for Estrogen Receptor-beta Positive Triple Negative Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02089854

Link

https://clinicaltrials.gov/show/NCT02089854

Keywords

Versions (1)
  1. 6/9/20 6/9/20 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

June 9, 2020

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Female Breast Cancer NCT02089854

English

Eligibility Female Breast Cancer NCT02089854

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
the patients signed the written informed consent.
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
the patients present with histologically proven operable invasive breast cancers without distant metastasis.
Description

Invasive carcinoma of breast Operable | Distant metastasis Absent

Data type

boolean

Alias
UMLS CUI [1,1]
C0853879
UMLS CUI [1,2]
C0205188
UMLS CUI [2,1]
C1269798
UMLS CUI [2,2]
C0332197
the breast tumor's positive er/pr rate is <1%, and positive er-beta rate is ≥1% by immuno-histochemistry(ihc).
Description

Oestrogen receptor positive breast cancer Immunohistochemistry | Breast Carcinoma Progesterone receptor positive Immunohistochemistry | Breast Carcinoma Estrogen Receptor beta Positive Immunohistochemistry

Data type

boolean

Alias
UMLS CUI [1,1]
C2938924
UMLS CUI [1,2]
C0021044
UMLS CUI [2,1]
C0678222
UMLS CUI [2,2]
C0279759
UMLS CUI [2,3]
C0021044
UMLS CUI [3,1]
C0678222
UMLS CUI [3,2]
C0529099
UMLS CUI [3,3]
C1514241
UMLS CUI [3,4]
C0021044
the patients have no history of neoadjuvant hormone therapy.
Description

Hormone Therapy Neoadjuvant Absent

Data type

boolean

Alias
UMLS CUI [1,1]
C0279025
UMLS CUI [1,2]
C0600558
UMLS CUI [1,3]
C0332197
the patients' karnofsky performance score ≥70%.
Description

Karnofsky Performance Status

Data type

boolean

Alias
UMLS CUI [1]
C0206065
female patient who is ≥ 18yrs, and ≤ 80yrs.
Description

Gender Age

Data type

boolean

Alias
UMLS CUI [1,1]
C0079399
UMLS CUI [1,2]
C0001779
the patients are non-pregnant, and disposed to practice contraception during the whole trial.
Description

Pregnancy Absent | Contraceptive methods

Data type

boolean

Alias
UMLS CUI [1,1]
C0032961
UMLS CUI [1,2]
C0332197
UMLS CUI [2]
C0700589
the patients underwent neoadjuvant chemotherapy plus surgery or directly modified radical mastectomy or breast-conserving surgery (plus sentinel lymph node biopsy or axillary lymph node dissection) after diagnosis of breast cancer.
Description

Chemotherapy Neo-adjuvant | Operative Surgical Procedures | Modified radical mastectomy Directly | Breast-Conserving Surgery | Sentinel Lymph Node Biopsy | Excision of axillary lymph nodes | Status post Diagnosis Breast Carcinoma

Data type

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C1298676
UMLS CUI [2]
C0543467
UMLS CUI [3,1]
C0024883
UMLS CUI [3,2]
C1947931
UMLS CUI [4]
C0917927
UMLS CUI [5]
C0796693
UMLS CUI [6]
C0193867
UMLS CUI [7,1]
C0231290
UMLS CUI [7,2]
C0011900
UMLS CUI [7,3]
C0678222
the patients underwent chemotherapy, radiation therapy after surgery according to the 2013 nccn guideline.
Description

Chemotherapy | Therapeutic radiology procedure | Status post Operative Surgical Procedures

Data type

boolean

Alias
UMLS CUI [1]
C0392920
UMLS CUI [2]
C1522449
UMLS CUI [3,1]
C0231290
UMLS CUI [3,2]
C0543467
the results of patients' blood tests are as follows:
Description

Hematologic Tests

Data type

boolean

Alias
UMLS CUI [1]
C0018941
hb≥90g/l; wbc≥4.0×109/l; neutrophils≥1.5×109/l; plt≥100×109/l; alanine aminotransferase(alt) and aspartate aminotransferase (ast) ≤ 2.5 × upper limit of normal(uln); total bilirubin(tbil) ≤ 1.5×uln; creatinine ≤ 1.25×uln.
Description

Hemoglobin measurement | White Blood Cell Count procedure | Neutrophil count | Platelet Count measurement | Alanine aminotransferase measurement | Aspartate aminotransferase measurement | Serum total bilirubin measurement

Data type

boolean

Alias
UMLS CUI [1]
C0518015
UMLS CUI [2]
C0023508
UMLS CUI [3]
C0200633
UMLS CUI [4]
C0032181
UMLS CUI [5]
C0201836
UMLS CUI [6]
C0201899
UMLS CUI [7]
C1278039
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
the patients have a previous history of invasive malignant disease (breast cancer at any time, other malignant disorders within the past 10 years excluding squamous or basal-cell carcinoma of the skin or carcinoma in situ of the cervix, adequately cone biopsied).
Description

Malignant disease Invasive | Breast Carcinoma | Cancer Other | Exception Squamous cell carcinoma of skin | Exception Basal cell carcinoma | Exception Conization Carcinoma in situ of uterine cervix

Data type

boolean

Alias
UMLS CUI [1,1]
C0442867
UMLS CUI [1,2]
C0205281
UMLS CUI [2]
C0678222
UMLS CUI [3]
C1707251
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C0553723
UMLS CUI [5,1]
C1705847
UMLS CUI [5,2]
C0007117
UMLS CUI [6,1]
C1705847
UMLS CUI [6,2]
C0195324
UMLS CUI [6,3]
C0851140
the patients have any severe concomitant disease which will place the patient at unusual risk or confound the results of the trial.
Description

Comorbidity Severe At risk Patient | Comorbidity Severe Interferes with Research results

Data type

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0205082
UMLS CUI [1,3]
C1444641
UMLS CUI [1,4]
C0030705
UMLS CUI [2,1]
C0009488
UMLS CUI [2,2]
C0205082
UMLS CUI [2,3]
C0521102
UMLS CUI [2,4]
C0683954
the patients have history of neoadjuvant hormone therapy.
Description

Hormone Therapy Neoadjuvant

Data type

boolean

Alias
UMLS CUI [1,1]
C0279025
UMLS CUI [1,2]
C0600558
the patients are undergoing current administration of anti-cancer therapies, or are attending other clinical trials.
Description

Cancer treatment | Study Subject Participation Status | Clinical Trial

Data type

boolean

Alias
UMLS CUI [1]
C0920425
UMLS CUI [2]
C2348568
UMLS CUI [3]
C0008976
the patients are pregnant or lactational, or they refuse to practice contraception during the whole trial.
Description

Pregnancy | Breast Feeding | Contraceptive methods Refused

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3,1]
C0700589
UMLS CUI [3,2]
C1705116
the patients are unwilling to stop any hormonal drug including hormone replacement therapy(hrt).
Description

Hormone drug Discontinue Unwilling | Hormone replacement therapy Discontinue Unwilling

Data type

boolean

Alias
UMLS CUI [1,1]
C0019932
UMLS CUI [1,2]
C1444662
UMLS CUI [1,3]
C0558080
UMLS CUI [2,1]
C0282402
UMLS CUI [2,2]
C1444662
UMLS CUI [2,3]
C0558080
the patients can't understand the written informed consent; such as they have dementia.
Description

Informed Consent Comprehension Unable | Dementia

Data type

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C0162340
UMLS CUI [1,3]
C1299582
UMLS CUI [2]
C0497327
the patients have allergic history or contraindication of toremifene/anastrozole.
Description

Hypersensitivity Toremifene | Medical contraindication Toremifene | Hypersensitivity Anastrozole | Medical contraindication Anastrozole

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0076836
UMLS CUI [2,1]
C1301624
UMLS CUI [2,2]
C0076836
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C0290883
UMLS CUI [4,1]
C1301624
UMLS CUI [4,2]
C0290883
Back to the top of the page

Similar models

Eligibility Female Breast Cancer NCT02089854

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Informed Consent
Item
the patients signed the written informed consent.
boolean
C0021430 (UMLS CUI [1])
Invasive carcinoma of breast Operable | Distant metastasis Absent
Item
the patients present with histologically proven operable invasive breast cancers without distant metastasis.
boolean
C0853879 (UMLS CUI [1,1])
C0205188 (UMLS CUI [1,2])
C1269798 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Oestrogen receptor positive breast cancer Immunohistochemistry | Breast Carcinoma Progesterone receptor positive Immunohistochemistry | Breast Carcinoma Estrogen Receptor beta Positive Immunohistochemistry
Item
the breast tumor's positive er/pr rate is <1%, and positive er-beta rate is ≥1% by immuno-histochemistry(ihc).
boolean
C2938924 (UMLS CUI [1,1])
C0021044 (UMLS CUI [1,2])
C0678222 (UMLS CUI [2,1])
C0279759 (UMLS CUI [2,2])
C0021044 (UMLS CUI [2,3])
C0678222 (UMLS CUI [3,1])
C0529099 (UMLS CUI [3,2])
C1514241 (UMLS CUI [3,3])
C0021044 (UMLS CUI [3,4])
Hormone Therapy Neoadjuvant Absent
Item
the patients have no history of neoadjuvant hormone therapy.
boolean
C0279025 (UMLS CUI [1,1])
C0600558 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
Karnofsky Performance Status
Item
the patients' karnofsky performance score ≥70%.
boolean
C0206065 (UMLS CUI [1])
Gender Age
Item
female patient who is ≥ 18yrs, and ≤ 80yrs.
boolean
C0079399 (UMLS CUI [1,1])
C0001779 (UMLS CUI [1,2])
Pregnancy Absent | Contraceptive methods
Item
the patients are non-pregnant, and disposed to practice contraception during the whole trial.
boolean
C0032961 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0700589 (UMLS CUI [2])
Chemotherapy Neo-adjuvant | Operative Surgical Procedures | Modified radical mastectomy Directly | Breast-Conserving Surgery | Sentinel Lymph Node Biopsy | Excision of axillary lymph nodes | Status post Diagnosis Breast Carcinoma
Item
the patients underwent neoadjuvant chemotherapy plus surgery or directly modified radical mastectomy or breast-conserving surgery (plus sentinel lymph node biopsy or axillary lymph node dissection) after diagnosis of breast cancer.
boolean
C0392920 (UMLS CUI [1,1])
C1298676 (UMLS CUI [1,2])
C0543467 (UMLS CUI [2])
C0024883 (UMLS CUI [3,1])
C1947931 (UMLS CUI [3,2])
C0917927 (UMLS CUI [4])
C0796693 (UMLS CUI [5])
C0193867 (UMLS CUI [6])
C0231290 (UMLS CUI [7,1])
C0011900 (UMLS CUI [7,2])
C0678222 (UMLS CUI [7,3])
Chemotherapy | Therapeutic radiology procedure | Status post Operative Surgical Procedures
Item
the patients underwent chemotherapy, radiation therapy after surgery according to the 2013 nccn guideline.
boolean
C0392920 (UMLS CUI [1])
C1522449 (UMLS CUI [2])
C0231290 (UMLS CUI [3,1])
C0543467 (UMLS CUI [3,2])
Hematologic Tests
Item
the results of patients' blood tests are as follows:
boolean
C0018941 (UMLS CUI [1])
Hemoglobin measurement | White Blood Cell Count procedure | Neutrophil count | Platelet Count measurement | Alanine aminotransferase measurement | Aspartate aminotransferase measurement | Serum total bilirubin measurement
Item
hb≥90g/l; wbc≥4.0×109/l; neutrophils≥1.5×109/l; plt≥100×109/l; alanine aminotransferase(alt) and aspartate aminotransferase (ast) ≤ 2.5 × upper limit of normal(uln); total bilirubin(tbil) ≤ 1.5×uln; creatinine ≤ 1.25×uln.
boolean
C0518015 (UMLS CUI [1])
C0023508 (UMLS CUI [2])
C0200633 (UMLS CUI [3])
C0032181 (UMLS CUI [4])
C0201836 (UMLS CUI [5])
C0201899 (UMLS CUI [6])
C1278039 (UMLS CUI [7])
Item Group
C0680251 (UMLS CUI)
Malignant disease Invasive | Breast Carcinoma | Cancer Other | Exception Squamous cell carcinoma of skin | Exception Basal cell carcinoma | Exception Conization Carcinoma in situ of uterine cervix
Item
the patients have a previous history of invasive malignant disease (breast cancer at any time, other malignant disorders within the past 10 years excluding squamous or basal-cell carcinoma of the skin or carcinoma in situ of the cervix, adequately cone biopsied).
boolean
C0442867 (UMLS CUI [1,1])
C0205281 (UMLS CUI [1,2])
C0678222 (UMLS CUI [2])
C1707251 (UMLS CUI [3])
C1705847 (UMLS CUI [4,1])
C0553723 (UMLS CUI [4,2])
C1705847 (UMLS CUI [5,1])
C0007117 (UMLS CUI [5,2])
C1705847 (UMLS CUI [6,1])
C0195324 (UMLS CUI [6,2])
C0851140 (UMLS CUI [6,3])
Comorbidity Severe At risk Patient | Comorbidity Severe Interferes with Research results
Item
the patients have any severe concomitant disease which will place the patient at unusual risk or confound the results of the trial.
boolean
C0009488 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C1444641 (UMLS CUI [1,3])
C0030705 (UMLS CUI [1,4])
C0009488 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0521102 (UMLS CUI [2,3])
C0683954 (UMLS CUI [2,4])
Hormone Therapy Neoadjuvant
Item
the patients have history of neoadjuvant hormone therapy.
boolean
C0279025 (UMLS CUI [1,1])
C0600558 (UMLS CUI [1,2])
Cancer treatment | Study Subject Participation Status | Clinical Trial
Item
the patients are undergoing current administration of anti-cancer therapies, or are attending other clinical trials.
boolean
C0920425 (UMLS CUI [1])
C2348568 (UMLS CUI [2])
C0008976 (UMLS CUI [3])
Pregnancy | Breast Feeding | Contraceptive methods Refused
Item
the patients are pregnant or lactational, or they refuse to practice contraception during the whole trial.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0700589 (UMLS CUI [3,1])
C1705116 (UMLS CUI [3,2])
Hormone drug Discontinue Unwilling | Hormone replacement therapy Discontinue Unwilling
Item
the patients are unwilling to stop any hormonal drug including hormone replacement therapy(hrt).
boolean
C0019932 (UMLS CUI [1,1])
C1444662 (UMLS CUI [1,2])
C0558080 (UMLS CUI [1,3])
C0282402 (UMLS CUI [2,1])
C1444662 (UMLS CUI [2,2])
C0558080 (UMLS CUI [2,3])
Informed Consent Comprehension Unable | Dementia
Item
the patients can't understand the written informed consent; such as they have dementia.
boolean
C0021430 (UMLS CUI [1,1])
C0162340 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,3])
C0497327 (UMLS CUI [2])
Hypersensitivity Toremifene | Medical contraindication Toremifene | Hypersensitivity Anastrozole | Medical contraindication Anastrozole
Item
the patients have allergic history or contraindication of toremifene/anastrozole.
boolean
C0020517 (UMLS CUI [1,1])
C0076836 (UMLS CUI [1,2])
C1301624 (UMLS CUI [2,1])
C0076836 (UMLS CUI [2,2])
C0020517 (UMLS CUI [3,1])
C0290883 (UMLS CUI [3,2])
C1301624 (UMLS CUI [4,1])
C0290883 (UMLS CUI [4,2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial